Overview

Indian Glaucoma and Cataract Surgery Devices Market is poised to value over USD 520.7 million by 2028 end at a CAGR of over 10.2% during the forecast period 2021 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Indian Glaucoma and Cataract Surgery Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Indian Glaucoma and Cataract Surgery Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Indian Glaucoma and Cataract Surgery Devices Market:
• Alcon, Inc. (Novartis AG)
• New World Medical, Inc.
• Johnson & Johnson
• Bausch & Lomb, Inc. (Valeant Pharmaceuticals International, Inc.)
• Topcon Corporation
• Lumenis Ltd.
• Allergan plc
• Carl Zeiss Meditec AG
• Essilor International S.A.
• HAAG-Streit Holding AG
• Nidek Co., Ltd
• Ziemer Ophthalmic Systems AG
• Ellex Medical Lasers Ltd
• Santen Pharmaceutical Co., Ltd.
• Abbott Laboratories, Inc.
• Zabbys
• STAAR Surgical Company
• Hoya Corporation
• Aurolab
(Note: The list of the major players will be updated with the latest market scenario and trends)

Indian Glaucoma and Cataract Surgery Devices Market Segmentation:
By Product Type
• Glaucoma Surgery Device
  o Implant & Stent
  o Glaucoma Drainage
  o Glaucoma Laser Device
• Cataract Surgery Device
  o Intraocular Lens
  o Ophthalmic Viscoelastic Device
  o Phacoemulsification System

By Surgery Type
• Glaucoma Surgery
  o Conventional Glaucoma Surgery
  o Minimally Invasive Glaucoma Surgery
• Cataract Surgery
  o Phacoemulsification
  o Extracapsular Cataract Extraction (ECCE) Surgery
  o Femtosecond Laser Surgery
  o Others

By End-User
• Hospitals
• Ophthalmology Clinic
• Outpatient Surgery Center

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Indian Glaucoma and Cataract Surgery Devices Market By Product Type, By Surgery Type and By End-User.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— India.
• To record and evaluate competitive landscape mapping- Product Type launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1 Objectives of the Study
  1.2 Market Definition
  1.3 Market Scope
      1.3.1 Years Considered for the Study
      1.3.2 Market Covered
  1.4 Currency
  1.5 Limitations
  1.6 Stakeholders

2. Research Methodology
   2.1 Research Data
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation
   2.3 Market Breakdown and Data Triangulation
   2.4 Assumptions for the Study  

3. Executive Summary
  3.1 Market Outlook
  3.2 Segment Outlook
  3.3 Competitive Insights

4. Global Indian Glaucoma and Cataract Surgery Devices Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Indian Glaucoma and Cataract Surgery Devices Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Indian Glaucoma and Cataract Surgery Devices Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Indian Glaucoma and Cataract Surgery Devices Market, By Product Type Historical Analysis and Forecast 2021-2028 (USD Million)
  7.1. Glaucoma Surgery Device
         7.1.1. Implant & Stent
         7.1.2. Glaucoma Drainage
         7.1.3. Glaucoma Laser Device
  7.2. Cataract Surgery Device
         7.2.1. Intraocular Lens
         7.2.2. Ophthalmic Viscoelastic Device
        7.2.3. Phacoemulsification System

8. Indian Glaucoma and Cataract Surgery Devices Market, By Surgery Type Historical Analysis and Forecast 2021-2028 (USD Million)  
  8.1. Glaucoma Surgery
         8.1.1. Conventional Glaucoma Surgery
         8.1.2. Minimally Invasive Glaucoma Surgery
  8.2. Cataract Surgery
         8.2.1. Phacoemulsification
         8.2.2. Extracapsular Cataract Extraction (ECCE) Surgery
         8.2.3. Femtosecond Laser Surgery
         8.2.4. Others

9. Indian Glaucoma and Cataract Surgery Devices Market, By End-User Historical Analysis and Forecast 2021-2028 (USD Million)  
  9.1. Hospitals
  9.2. Ophthalmology Clinic
  9.3. Outpatient Surgery Center

10. Market Share Analysis and Competitive Landscape  
   10.1. Indian Landscape - Key Players, Revenue and Presence
   10.2. Indian Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   10.3. Indian Emerging Companies
   10.4. India - Market Share Analysis and Key Regional Players
   10.5. Indian Key Player - Growth Matrix

11. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Types Offered and Financial Layouts)
   11.1. Alcon, Inc. (Novartis AG)
         11.1.1. Company Overview
         11.1.2. Product Portfolio
         11.1.3. SWOT Analysis
         11.1.4. Financial Overview
         11.1.5. Strategic Overview
   11.2. New World Medical, Inc.
         11.2.1. Company Overview
         11.2.2. Product Portfolio
         11.2.3. SWOT Analysis
         11.2.4. Financial Overview
         11.2.5. Strategic Overview
   11.3. Johnson & Johnson
         11.3.1. Company Overview
         11.3.2. Product Portfolio
         11.3.3. SWOT Analysis
         11.3.4. Financial Overview
         11.3.5. Strategic Overview
   11.4. Bausch & Lomb, Inc. (Valeant Pharmaceuticals International, Inc.)
         11.4.1. Company Overview
         11.4.2. Product Portfolio
         11.4.3. SWOT Analysis
         11.4.4. Financial Overview
         11.4.5. Strategic Overview
   11.5. Topcon Corporation
         11.5.1. Company Overview
         11.5.2. Product Portfolio
         11.5.3. SWOT Analysis
         11.5.4. Financial Overview
         11.5.5. Strategic Overview          
   11.6. Lumenis Ltd.
         11.6.1. Company Overview
         11.6.2. Product Portfolio
         11.6.3. SWOT Analysis
         11.6.4. Financial Overview
         11.6.5. Strategic Overview      
   11.7. Allergan plc
         11.7.1. Company Overview
         11.7.2. Product Portfolio
         11.7.3. SWOT Analysis
         11.7.4. Financial Overview
         11.7.5. Strategic Overview
   11.8. Carl Zeiss Meditec AG
         11.8.1. Company Overview
         11.8.2. Product Portfolio
         11.8.3. SWOT Analysis
         11.8.4. Financial Overview
         11.8.5. Strategic Overview
   11.9. Essilor International S.A.
         11.9.1. Company Overview
         11.9.2. Product Portfolio
         11.9.3. SWOT Analysis
         11.9.4. Financial Overview
         11.9.5. Strategic Overview
   11.10.HAAG-Streit Holding AG
         11.10.1. Company Overview
         11.10.2. Product Portfolio
         11.10.3. SWOT Analysis
         11.10.4. Financial Overview
         11.10.5. Strategic Overview
   11.11.Nidek Co., Ltd
         11.11.1. Company Overview
         11.11.2. Product Portfolio
         11.11.3. SWOT Analysis
         11.11.4. Financial Overview
         11.11.5. Strategic Overview
   11.12.Ziemer Ophthalmic Systems AG
         11.12.1. Company Overview
         11.12.2. Product Portfolio
         11.12.3. SWOT Analysis
         11.12.4. Financial Overview
         11.12.5. Strategic Overview
   11.13.Ellex Medical Lasers Ltd
         11.13.1. Company Overview
         11.13.2. Product Portfolio
         11.13.3. SWOT Analysis
         11.13.4. Financial Overview
         11.13.5. Strategic Overview
   11.14.Santen Pharmaceutical Co., Ltd.
         11.14.1. Company Overview
         11.14.2. Product Portfolio
         11.14.3. SWOT Analysis
         11.14.4. Financial Overview
         11.14.5. Strategic Overview
   11.15.Abbott Laboratories, Inc.
         11.15.1. Company Overview
         11.15.2. Product Portfolio
         11.15.3. SWOT Analysis
         11.15.4. Financial Overview
         11.15.5. Strategic Overview
   11.16.Zabbys
         11.16.1. Company Overview
         11.16.2. Product Portfolio
         11.16.3. SWOT Analysis
         11.16.4. Financial Overview
         11.16.5. Strategic Overview
   11.17.STAAR Surgical Company
         11.17.1. Company Overview
         11.17.2. Product Portfolio
         11.17.3. SWOT Analysis
         11.17.4. Financial Overview
         11.17.5. Strategic Overview
   11.18.Hoya Corporation
         11.18.1. Company Overview
         11.18.2. Product Portfolio
         11.18.3. SWOT Analysis
         11.18.4. Financial Overview
         11.18.5. Strategic Overview  
   11.19.Aurolab
         11.19.1. Company Overview
         11.19.2. Product Portfolio
         11.19.3. SWOT Analysis
         11.19.4. Financial Overview
         11.19.5. Strategic Overview  

12. Pre and Post COVID-19 Impact
   12.1. Positive influence on the healthcare industry
   12.2. The financial disruption of the manufacturing sector
   12.3. Impact of COVID-19 on emerging companies
   12.4. Significant mandates in the healthcare regulations initiated by administrations
   12.5. The overall economic slowdown of the developing and developed nations

13. FutureWise SME Key Takeaway Points for Client

Tables

Figures